Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451-AM1) (HACER)
This study has been withdrawn prior to enrollment.
( No patient enrolled after 6 months from the start. The decision to withdraw the study was based on a feasibility reevaluation conducted with investigators. )
Study NCT01148901
Information provided by Schering-Plough
First Received on June 21, 2010.
Last Updated on January 24, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
